WORXE Worlds Online Inc

MariMed Announces the Filing of its final Non-Offering Prospectus

MariMed Announces the Filing of its final Non-Offering Prospectus

Sets Stage For Dual Listing on the Canadian Securities Exchange

NORWOOD, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- (“MariMed” or the “Company”) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has obtained a receipt for its final non-offering, long form prospectus dated June 29, 2022 from the Ontario Securities Commission.

Concurrent with its prospectus filing, the Company also received conditional approval from the Canadian Securities Exchange (the “CSE”) to list the Company’s common shares on the CSE under the symbol "MRMD". Listing of the common shares is subject to the satisfaction of certain customary conditions, including the receipt by the CSE of all final documentation. The Company anticipates the dual listing on the CSE to be effective in July of 2022.

“Completing the prospectus filing process is the last significant milestone necessary to fulfill the Company’s goal of attaining a dual listing on the CSE,” said Susan Villare, Chief Financial Officer of MariMed. “We believe this listing will improve liquidity enabling increased trading volume and allow for more accessible trading for some investors that currently cannot invest in MariMed.”

A copy of the final Prospectus is available under the Company’s profile on SEDAR at .

ABOUT MARIMED

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit .

For More Information, Contact:

Investor Relations:

Steve West, Vice President, Investor Relations

Email:

Media Contact:

Howard Schacter, Chief Communications Officer

Email:

 



EN
30/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed’s Premium Nature’s Heritage Brand Enters Functional Mushroom M...

MariMed’s Premium Nature’s Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose All-Natural Line of Wellness Products Designed to Support Overall Well-Being Now Available in Massachusetts NORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature’s Heritage™, continued to drive innovation with the launch of MycroDose by Nature’s Heritage, a vegan line of all-natural wellness products that combine the power of full-spectrum cannabis with the added benef...

 PRESS RELEASE

MariMed Reports First Quarter 2025 Earnings

MariMed Reports First Quarter 2025 Earnings NORWOOD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2025. Management Commentary “We are executing on our vision to build the best consumer packaged goods company in cannabis, and over the past quarter we continued to penetrate more storefronts and capture more market share for our innovative, high-quality portfolio of brand...

 PRESS RELEASE

MariMed Announces First Quarter 2025 Earnings Date

MariMed Announces First Quarter 2025 Earnings Date NORWOOD, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- . (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report first quarter 2025 financial results on May 7, 2025 after the markets close. Management will host a conference call on May 8, 2025 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will also be made available on MariMed’s Invest...

 PRESS RELEASE

MariMed Promotes Ryan Crandall to Chief Commercial Officer

MariMed Promotes Ryan Crandall to Chief Commercial Officer NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- . (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was the Company’s Chief Products Officer and SVP, ...

 PRESS RELEASE

MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction o...

MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews Each Betty’s Caramelt Away Chew Uses Rich, Buttery Caramel, To Create Moments of Mellow NORWOOD, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- ™, the all-natural cannabis chews handcrafted to fit a variety of needs, is expanding its lineup with the introduction of delicious caramel chews: Betty’s Caramelt Away. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: M...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch